FA complementation group A | OKDB#: 911 |
Symbols: | FANCA | Species: | human | ||
Synonyms: | FA, FA1, FAA, FAH, FA-H, FACA, FANCH | Locus: | 16q24.3 in Homo sapiens |
For retrieval of Nucleotide and Amino Acid sequences please go to:
OMIM
Entrez Gene
Mammalian Reproductive Genetics Endometrium Database Resource Orthologous Genes UCSC Genome Browser GEO Profiles new! Amazonia (transcriptome data) new! R-L INTERACTIONS MGI |
General Comment |
Fanconi anemia (FA) is an autosomal recessive disorder in humans characterized by bone marrow
failure, cancer predisposition, and cellular hypersensitivity to cross-linking agents such as mitomycin
C and diepoxybutane. FA genes display a caretaker function essential for maintenance of genomic
integrity.
NCBI Summary: The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008] |
||||
General function | Cell death/survival, DNA Replication | ||||
Comment | Fujiwara et al. (1977) presented evidence that Fanconi anemia fibroblasts have an impaired capacity of removing DNA interstrand crosslinks induced by mitomycin C. They favored the view that a DNA crosslink repair deficiency is responsible for chromosomal damage in this disorder. van de Vrugt HJ, et al 2000 have cloned the murine homolog of FANCA, the gene mutated in the major FA complementation group (FA-A). The full-length mouse Fanca cDNA consists of 4503 bp and encodes a protein with a predicted molecular weight of 161 kDa. The deduced Fanca mouse protein shares 81% amino acid sequence similarity and 66% identity with the human protein. The nuclear localization signal and partial leucine zipper consensus motifs found in the human FANCA protein were also present in the murine homolog. In spite of the species difference, the murine Fanca cDNA was capable of correcting the cross-linker sensitive phenotype of human FA-A cells, suggesting functional conservation. Based on Northern as well as Western blots, Fanca was mainly expressed in lymphoid tissues, testis, and ovary. This expression pattern correlates with some of the clinical symptoms observed in FA patients. The availability of the murine Fanca cDNA now allows the gene to be studied in experimental mouse models. | ||||
Cellular localization | Nuclear | ||||
Comment | |||||
Ovarian function | Germ cell development | ||||
Comment | |||||
Expression regulated by | |||||
Comment | |||||
Ovarian localization | |||||
Comment | van de Vrugt HJ, et al 2000 reported cloning and characterization of murine Fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. | ||||
Follicle stages | |||||
Comment | |||||
Phenotypes | |||||
Mutations |
4 mutations
Species: human
Species: mouse
Species: mouse
Species: human
|
||||
Genomic Region | show genomic region | ||||
Phenotypes and GWAS | show phenotypes and GWAS | ||||
Links |
|
created: | April 9, 2000, midnight | by: |
hsueh email:
home page: |
last update: | April 13, 2020, 2:24 p.m. | by: | hsueh email: |
Click here to return to gene search form